Last reviewed · How we verify
Tranexamic Acid 500 MG
At a glance
| Generic name | Tranexamic Acid 500 MG |
|---|---|
| Also known as | TXA |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effects of Red and Infrared Photobiomodulation in Rhinoplasty at a Single Centre (NA)
- Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial (PHASE3)
- Clinical Randomisation of an Anti-fibrinolytic in Symptomatic Mild Head Injury in Older Adults (PHASE3)
- Nebulized Tranexamic Acid in Sinus Surgery (PHASE3)
- Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery (EARLY_PHASE1)
- Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage (PHASE4)
- A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients (PHASE3)
- TranExamic Atomized for Pediatric Post-Operative Tonsillectomy Hemorrhage: Pilot Study (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |